Stock listing

OTC:BIXT Bioxytran, Inc. Stock

Follow Bioxytran, Inc. into a list and get an email when it puts out news.

Share price · OTC:BIXT

$0.023 USD +0.002 (+8.4%)

Close on Nov 17, 2026

Past year -62.5% · daily closes, Nov 17, 2025 – Nov 17, 2026, adjusted for splits
Day range
$0.023 – $0.023 USDNov 17, 2026
Volume
30,000 sharesNov 17, 2026
Market cap
$2.66M USDAt the close on Nov 17, 2026 · price × 114.7M shares outstanding
52-week range
$0.020 – $0.095 USDLowest and highest trades, Nov 18, 2025 – Nov 17, 2026
Traded on an average day
$2,043 USDMedian day 46,506 shares · 3 days with no trades · last 3 months, Aug 17, 2026 – Nov 17, 2026
Bioxytran, Inc. logo

Daily closes

Last 3 months, Aug 17, 2026 – Nov 17, 2026 · OTC:BIXT · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.023+0.002+8.4%$0.023$0.023$0.02330,000
$0.021-0.002-7.0%$0.021$0.021$0.020285,072
$0.023+0.002+9.0%$0.023$0.023$0.02320,000
$0.021-0.002-9.1%$0.021$0.021$0.0211,400
$0.023+0.003+15.4%$0.021$0.023$0.02143,500
$0.020-0.001-5.2%$0.021$0.021$0.02045,000
$0.021-0.002-8.2%$0.022$0.024$0.02171,180
$0.0230.0000.0%$0.023$0.023$0.0230
$0.0230.000-1.7%$0.024$0.024$0.02231,500
$0.0240.0000.0%$0.024$0.024$0.0240
$0.024+0.001+4.9%$0.024$0.024$0.02257,417
$0.022-0.001-3.9%$0.022$0.023$0.0225,508
$0.0230.000-0.4%$0.023$0.023$0.023344
$0.023+0.000+1.7%$0.022$0.023$0.02267,358
$0.023+0.001+2.7%$0.023$0.023$0.02293,000
$0.0220.000-1.3%$0.024$0.024$0.02230,304
$0.0230.000-0.9%$0.023$0.023$0.02313,700
$0.023-0.001-2.6%$0.022$0.023$0.02212,000
$0.024+0.001+4.9%$0.022$0.024$0.02214,700
$0.022+0.000+0.4%$0.024$0.024$0.02232,809
$0.022+0.000+0.9%$0.025$0.025$0.02265,110
$0.022-0.002-7.5%$0.023$0.024$0.022138,666
$0.024+0.001+5.8%$0.022$0.024$0.02266,600
$0.023-0.001-5.4%$0.023$0.023$0.022161,600
$0.024+0.000+0.4%$0.024$0.024$0.022170,237
$0.024+0.003+12.8%$0.023$0.024$0.023167,090
$0.0210.0000.0%$0.021$0.021$0.0210
$0.021+0.001+5.0%$0.021$0.021$0.02124,000
$0.020-0.003-13.4%$0.023$0.024$0.020104,010
$0.023+0.002+8.9%$0.022$0.024$0.02272,107
$0.021+0.001+6.0%$0.020$0.023$0.020141,800
$0.020-0.001-6.1%$0.022$0.022$0.02092,763
$0.021-0.002-8.2%$0.022$0.022$0.02126,012
$0.0230.000-0.4%$0.022$0.023$0.02148,011
$0.023+0.000+1.7%$0.023$0.023$0.020220,150
$0.023+0.001+2.7%$0.022$0.024$0.02220,820
$0.022-0.001-3.4%$0.022$0.022$0.02220,000
$0.023+0.002+10.0%$0.023$0.024$0.02036,330
$0.0210.000-1.4%$0.022$0.022$0.02055,350
$0.021+0.001+5.4%$0.022$0.023$0.02075,672
$0.020-0.001-3.3%$0.020$0.023$0.02090,450
$0.021+0.001+4.0%$0.021$0.021$0.02069,990
$0.020-0.001-4.3%$0.021$0.021$0.02020,000
$0.021+0.000+1.0%$0.021$0.021$0.02036,518
$0.021+0.000+0.5%$0.021$0.021$0.02021,000
$0.021-0.002-8.0%$0.023$0.023$0.02198,675
$0.023-0.001-3.4%$0.024$0.024$0.02322,000
$0.023+0.001+2.6%$0.022$0.023$0.02279,449
$0.023-0.001-2.6%$0.024$0.024$0.0238,000
$0.0230.0000.0%$0.023$0.023$0.023600
$0.023+0.002+9.9%$0.023$0.023$0.02144,000
$0.0210.000-1.4%$0.020$0.022$0.020156,560
$0.0220.000-0.5%$0.022$0.024$0.022419,380
$0.022+0.000+1.4%$0.021$0.022$0.020969,600
$0.021-0.005-18.3%$0.022$0.025$0.020367,230
$0.026+0.005+24.8%$0.021$0.026$0.021199,079

Splits

2 splits since 2011 · OTC:BIXT · every price before a split is adjusted for it

DayRatioWhat
1-for-50Consolidation
3-for-1Split
Ticker
OTC:BIXT
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
OTC
Currency
USD

What changed lately

Latest news

All Bioxytran, Inc. news

Bioxytran, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
3 in the last 12 months · 3 in all · newest Nov 16, 2026 · oldest 2026
Decks
14 decks · latest October 2025

Cash and shares

Oct 2025 deck · Bioxytran — Investor Presentation (October 2025)

Fully diluted
319 million

The slide these figures come from

Valuation

Statements: 4 quarters to Sep 30, 2026 · price Nov 17, 2026

Enterprise value
$2.59M USD
P/E
Loss
EV/sales
No revenue
EV/EBITDA
No depreciation figure on 6ix yet
Price/book
Negative equity
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
Negative equity
Beta vs S&P 500
-1.20

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Bioxytran, Inc. · OTC:BIXTUS$2.66MUS$2.59Mn/an/an/an/an/an/a-1.20
Gelteq Limited · NASDAQ:GELSUS$2.89MUS$6.27Mn/a57.2×n/a0.3×n/a0.4×0.83
Curis, Inc. · NASDAQ:CRISUS$2.85M−US$1.42Mn/an/an/a1.1×n/a0.3×1.85
Fluicell AB · OMXSTO:FLUIUS$2.83MUS$3.03M10.4×1.6×10.7×1.8×14.1%0.1×n/a
Alligator Bioscience AB · OMXSTO:ATORXUS$2.79MUS$1.47Mn/a53.3×n/a1.2×n/a1.2×n/a
Traws Pharma, Inc. · NASDAQ:TRAWUS$2.69MUS$351,448n/an/an/an/an/an/a2.07
NextCell Pharma AB · OMXSTO:NXTCLUS$2.69MUS$626,140n/a0.6×n/a0.6×−440.8%0.0×n/a
BioAtla, Inc. · NASDAQ:BCABUS$2.58MUS$2.01Mn/an/an/an/an/an/a-0.34
Invion Ltd. · ASX:IVXUS$2.49MUS$3.12Mn/a12.2×n/a0.7×n/a0.3×n/a
GRI Bio, Inc. · NASDAQ:GRIUS$2.45M−US$6.99Mn/an/an/a0.3×n/a0.0×0.89
NeuroSense Therapeutics Ltd. · NASDAQ:NRSNUS$2.43MUS$2.20Mn/an/an/an/an/an/a1.41
Median of the othersUS$2.69MUS$1.74M10.4×12.2×10.7×0.7×−213.3%0.3×1.15

Forecasts

Analysts' consensus from EODHD, read Nov 11, 2026. Not 6ix's view and not investment advice.

Price target
2.71 USD · Analysts' mean

Team and board

Officers

OfficerRole
David PlattCEO & Chairman of the Board
Ola SoderquistCFO
Leslie AjayiCMO & Medical Advisory Board Chief

Board

DirectorRole
David PlattCEO & Chairman of the Board
Alan M. HobermanDirector
Dale H. ConawayDirector
Radka MilanovaDirector

Events

QuarterResultsShare move
Q2 2024Aug 14, 2024 · After close+5.0%
Q1 2024Apr 19, 2024 · After close+6.4%
Q4 2023Mar 22, 2024 · After close−4.3%
Q3 2023Nov 3, 2023 · Before open−1.2%
Q2 2023Jul 31, 2023 · After close0.0%
Q1 2023May 12, 2023 · Before open−6.3%
Q4 2022Mar 31, 2023 · After close−5.6%
Q3 2022Nov 10, 2022 · Before open+7.8%
Q2 2022Aug 15, 2022 · After close−9.2%
Q1 2022May 23, 2022+24.1%
All 15 quarters
QuarterResultsShare move
Q4 2021Mar 29, 2022 · Before open
Quarter to Sep 30, 2021Nov 17, 2021 · After close+380.0%
Quarter to Jun 30, 2021Aug 10, 2021 · After close+66.7%
Quarter to Mar 31, 2021Apr 9, 2021 · Before open
Quarter to Dec 31, 2020Mar 31, 2021

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (October 2025)Investor deck31 slidesOctober 2025
Investor Presentation (August 2025)Investor deck57 slidesAug 29, 2025
Investor Presentation (2025)Investor deck57 slidesJan 6, 2025
Investor Presentation (September 2023)Investor deck42 slidesSeptember 2023
Investor Presentation (August 2023)Investor deck43 slidesAug 25, 2023
Investor Presentation (August 2023)Investor deck75 slidesAugust 2023
Investor Presentation (December 2022)Investor deck32 slidesDec 14, 2022
Investor Presentation (January 2022)Investor deck35 slidesJan 14, 2022
Investor Presentation (March 2020)Investor deck51 slidesMar 30, 2020
Investor Presentation (March 2020)Investor deck52 slidesMar 12, 2020
All 14 decks
DeckKindSlidesDate
Investor Presentation (January 2020)Investor deck20 slidesJan 31, 2020
Investor Presentation (December 2019)Investor deck32 slidesDec 11, 2019
Investor Presentation (December 2019)Investor deck31 slidesDec 11, 2019
Investor Presentation (September 2018)Investor deck17 slidesSep 24, 2018

Open Decks

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue191.1K246.5K
Cost of revenue104.0K96.3K
Gross profit87.1K150.2K
Research and development454.0K112.3K1.15M1.28M2.01M544.5K
Selling, general and administrative397.7K821.5K
Operating income-1.84M-2.22M-3.80M-2.44M-4.21M-1.27M-1.63M-215.1K-310.6K-671.3K
Depreciation and amortization17.5K27.6K
EBITDA-293.1K-643.7K
Interest expense134.3K84.2K193.2K2.02M1.01M41.8K3.72K7.80K7.80K
Income before tax-2.12M-2.38M-4.56M-2.67M-4.53M-2.54M-1.86M-296.4K-696.8K
Income tax400
Net income-2.12M-2.37M-4.47M-2.47M-4.03M-2.54M-1.86M-296.4K-318.4K-696.8K
Earnings per share, basic-0.02-0.02-0.03-0.02-0.04-0.03-0.020.00-0.01-0.03
Earnings per share, diluted-0.02-0.02-0.03-0.02-0.04-0.03-0.020.00-0.01-0.03

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents509.9K5.15K26.1K295.4K72.4K41.7K169.6K36.4K11011.1K
Receivables50.0K23.0K9.60K
Inventory5.26K6.27K
Current assets513.5K5.15K26.1K295.4K72.4K316.4K219.6K36.4K11027.0K
Property, plant and equipment682.2K24.7K
Total assets658.6K138.7K139.4K370.9K119.3K326.4K219.6K36.4K11051.7K
Accounts payable709.7K
Current liabilities3.25M1.93M3.24M3.67M3.28M2.27M1.02M261.7K1.42K342.3K
Total liabilities3.25M1.93M3.24M3.67M3.28M2.27M1.02M261.7K1.42K342.3K
Shareholders' equity-2.59M-1.79M-3.10M-3.30M-3.16M-1.94M-799.3K-225.3K-1.31K-290.6K
Shares outstanding108.1M86.8M144.6M123.3M110.8M97.5M86.5M85.1M85.1M28.2M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-526.5K-381.3K-775.4K-1.80M-1.70M-1.10M-431.0K-185.9K-18.5K-42.4K
Cash from investing-23.1K-28.2K-44.3K-32.2K-36.9K-10.0K
Cash from financing1.05M388.6K550.4K2.06M1.76M981.1K564.3K222.2K22.7K50.0K
Change in cash504.8K-20.9K-269.3K223.0K30.7K-127.9K133.2K36.3K4.18K7.61K

Open Financials

Filings

FilingDateTypeFiled with
10-Q · Quarterly reportNov 20, 2026Quarterly reportSEC
NT 10-Q · Late filing noticeNov 16, 2026Explanation requestSEC
8-K · Current reportNov 16, 2026Current reportSEC
8-K · Current reportNov 4, 2026Current reportSEC
10-Q · Quarterly reportAug 14, 2026Quarterly reportSEC
8-K · Current reportAug 11, 2026Current reportSEC
10-Q · Quarterly reportMay 15, 2026Quarterly reportSEC
10-K · Annual reportApr 15, 2026Annual reportSEC
NT 10-K · Late filing noticeApr 1, 2026Explanation requestSEC
8-K · Current reportMar 20, 2026FinancingSEC
Show 200 filings
FilingDateTypeFiled with
8-K · Current reportMar 13, 2026Management or board changeSEC
8-K · Current reportMar 2, 2026Current reportSEC
8-K · Current reportFeb 17, 2026Material contractSEC
8-K · Current reportFeb 11, 2026Current reportSEC
8-K · Current reportJan 5, 2026Management or board changeSEC
8-K · Current reportDec 15, 2025Management or board changeSEC
4 · Change in ownershipNov 18, 2025Insider tradeSEC
4 · Change in ownershipNov 18, 2025Insider tradeSEC
4 · Change in ownershipNov 18, 2025Insider tradeSEC
4 · Change in ownershipNov 18, 2025Insider tradeSEC
4/A · Change in ownership, amendedNov 18, 2025Insider tradeSEC
4/A · Change in ownership, amendedNov 18, 2025Insider tradeSEC
4/A · Change in ownership, amendedNov 18, 2025Insider tradeSEC
10-Q · Quarterly reportNov 14, 2025Quarterly reportSEC
10-Q · Quarterly reportAug 11, 2025Quarterly reportSEC
10-Q · Quarterly reportMay 15, 2025Quarterly reportSEC
10-K · Annual reportApr 3, 2025Annual reportSEC
8-K/A · Current report, amendedApr 3, 2025Material contractSEC
NT 10-K · Late filing noticeMar 31, 2025Explanation requestSEC
424B4 · ProspectusFeb 18, 2025Offer documentSEC
EFFECT · Notice that a registration is effectiveFeb 18, 2025Other filingsSEC
CORRESP · Letter to the SECFeb 12, 2025Other filingsSEC
CORRESP · Letter to the SECFeb 12, 2025Other filingsSEC
S-1/A · Registration statement, amendedFeb 12, 2025Offer documentSEC
S-1/A · Registration statement, amendedFeb 5, 2025Offer documentSEC
UPLOAD · Letter from the SECFeb 4, 2025Other filingsSEC
DEL AMJan 23, 2025Other filingsSEC
S-1 · Registration statementJan 22, 2025Offer documentSEC
8-K · Current reportJan 22, 2025Material contractSEC
4 · Change in ownershipJan 14, 2025Insider tradeSEC
4 · Change in ownershipJan 14, 2025Insider tradeSEC
4 · Change in ownershipJan 14, 2025Insider tradeSEC
4 · Change in ownershipJan 14, 2025Insider tradeSEC
8-K · Current reportJan 13, 2025Current reportSEC
10-K/A · Annual report, amendedJan 13, 2025Annual reportSEC
8-K · Current reportJan 10, 2025Current reportSEC
10-Q · Quarterly reportOct 28, 2024Quarterly reportSEC
4 · Change in ownershipOct 28, 2024Insider tradeSEC
4 · Change in ownershipOct 28, 2024Insider tradeSEC
4 · Change in ownershipOct 28, 2024Insider tradeSEC
8-K · Current reportOct 28, 2024Material contractSEC
4 · Change in ownershipOct 28, 2024Insider tradeSEC
4 · Change in ownershipOct 28, 2024Insider tradeSEC
4 · Change in ownershipOct 28, 2024Insider tradeSEC
4 · Change in ownershipOct 28, 2024Insider tradeSEC
4 · Change in ownershipAug 20, 2024Insider tradeSEC
4 · Change in ownershipAug 20, 2024Insider tradeSEC
8-K · Current reportAug 20, 2024Current reportSEC
4 · Change in ownershipAug 20, 2024Insider tradeSEC
4 · Change in ownershipAug 20, 2024Insider tradeSEC
4 · Change in ownershipAug 20, 2024Insider tradeSEC
4 · Change in ownershipAug 20, 2024Insider tradeSEC
4 · Change in ownershipAug 20, 2024Insider tradeSEC
10-Q · Quarterly reportAug 14, 2024Quarterly reportSEC
8-K · Current reportJul 17, 2024Material contractSEC
RW · Request to withdraw a registrationJul 8, 2024Other filingsSEC
8-K · Current reportJul 3, 2024Current reportSEC
8-K · Current reportMay 9, 2024Current reportSEC
10-Q/A · Quarterly report, amendedApr 22, 2024Quarterly reportSEC
10-Q · Quarterly reportApr 19, 2024Quarterly reportSEC
8-K · Current reportApr 19, 2024Management or board changeSEC
4 · Change in ownershipApr 19, 2024Insider tradeSEC
4 · Change in ownershipApr 19, 2024Insider tradeSEC
4 · Change in ownershipApr 19, 2024Insider tradeSEC
3 · Initial statement of ownershipApr 19, 2024Insider tradeSEC
4 · Change in ownershipMar 27, 2024Insider tradeSEC
4 · Change in ownershipMar 27, 2024Insider tradeSEC
4 · Change in ownershipMar 27, 2024Insider tradeSEC
4 · Change in ownershipMar 27, 2024Insider tradeSEC
10-K · Annual reportMar 22, 2024Annual reportSEC
5 · Annual statement of ownershipJan 16, 2024Insider tradeSEC
5 · Annual statement of ownershipJan 16, 2024Insider tradeSEC
5 · Annual statement of ownershipJan 16, 2024Insider tradeSEC
4 · Change in ownershipJan 16, 2024Insider tradeSEC
5 · Annual statement of ownershipJan 16, 2024Insider tradeSEC
4 · Change in ownershipNov 2, 2023Insider tradeSEC
4 · Change in ownershipNov 2, 2023Insider tradeSEC
4 · Change in ownershipNov 2, 2023Insider tradeSEC
10-Q · Quarterly reportNov 2, 2023Quarterly reportSEC
4 · Change in ownershipOct 10, 2023Insider tradeSEC
424B4 · ProspectusOct 2, 2023Offer documentSEC
EFFECT · Notice that a registration is effectiveOct 2, 2023Other filingsSEC
CORRESP · Letter to the SECSep 28, 2023Other filingsSEC
S-1/A · Registration statement, amendedSep 26, 2023Offer documentSEC
UPLOAD · Letter from the SECSep 26, 2023Other filingsSEC
DEL AMSep 21, 2023Other filingsSEC
CORRESP · Letter to the SECSep 20, 2023Other filingsSEC
S-1 · Registration statementSep 19, 2023Offer documentSEC
4 · Change in ownershipSep 15, 2023Insider tradeSEC
4 · Change in ownershipAug 24, 2023Insider tradeSEC
4 · Change in ownershipAug 24, 2023Insider tradeSEC
4 · Change in ownershipAug 24, 2023Insider tradeSEC
4 · Change in ownershipAug 24, 2023Insider tradeSEC
4 · Change in ownershipAug 24, 2023Insider tradeSEC
8-K · Current reportAug 24, 2023Current reportSEC
EFFECT · Notice that a registration is effectiveAug 15, 2023Other filingsSEC
424B4 · ProspectusAug 14, 2023Offer documentSEC
CORRESP · Letter to the SECAug 10, 2023Other filingsSEC
S-1/A · Registration statement, amendedAug 8, 2023Offer documentSEC
S-1/A · Registration statement, amendedAug 2, 2023Offer documentSEC
10-Q · Quarterly reportJul 31, 2023Quarterly reportSEC
S-1/A · Registration statement, amendedJul 12, 2023Offer documentSEC
UPLOAD · Letter from the SECJul 12, 2023Other filingsSEC
S-1/A · Registration statement, amendedJul 7, 2023Offer documentSEC
UPLOAD · Letter from the SECJul 6, 2023Other filingsSEC
S-1/A · Registration statement, amendedJun 30, 2023Offer documentSEC
UPLOAD · Letter from the SECJun 29, 2023Other filingsSEC
S-1 · Registration statementJun 16, 2023Offer documentSEC
8-K · Current reportJun 12, 2023Material contractSEC
4 · Change in ownershipMay 17, 2023Insider tradeSEC
4 · Change in ownershipMay 17, 2023Insider tradeSEC
4 · Change in ownershipMay 17, 2023Insider tradeSEC
10-Q · Quarterly reportMay 12, 2023Quarterly reportSEC
4 · Change in ownershipMay 10, 2023Insider tradeSEC
4 · Change in ownershipMay 4, 2023Insider tradeSEC
4 · Change in ownershipMay 4, 2023Insider tradeSEC
4 · Change in ownershipMay 4, 2023Insider tradeSEC
4 · Change in ownershipMay 4, 2023Insider tradeSEC
10-K · Annual reportMar 31, 2023Annual reportSEC
DMar 13, 2023Other filingsSEC
8-K · Current reportMar 7, 2023Current reportSEC
RW · Request to withdraw a registrationMar 2, 2023Other filingsSEC
4 · Change in ownershipFeb 8, 2023Insider tradeSEC
5 · Annual statement of ownershipFeb 8, 2023Insider tradeSEC
5 · Annual statement of ownershipFeb 8, 2023Insider tradeSEC
5 · Annual statement of ownershipFeb 8, 2023Insider tradeSEC
5 · Annual statement of ownershipFeb 8, 2023Insider tradeSEC
5 · Annual statement of ownershipFeb 7, 2023Insider tradeSEC
5 · Annual statement of ownershipFeb 7, 2023Insider tradeSEC
5 · Annual statement of ownershipFeb 7, 2023Insider tradeSEC
8-K · Current reportFeb 6, 2023Current reportSEC
8-K · Current reportDec 14, 2022Current reportSEC
8-K · Current reportDec 8, 2022Current reportSEC
8-K · Current reportNov 16, 2022Current reportSEC
8-K · Current reportNov 14, 2022Material contractSEC
10-Q · Quarterly reportNov 10, 2022Quarterly reportSEC
RW · Request to withdraw a registrationSep 22, 2022Other filingsSEC
RW WDSep 21, 2022Other filingsSEC
8-K · Current reportAug 16, 2022Material contractSEC
DAug 16, 2022Other filingsSEC
SC 13D/A · Big-stake notice, amendedAug 16, 2022Big-stake noticeSEC
4 · Change in ownershipAug 16, 2022Insider tradeSEC
10-Q · Quarterly reportAug 15, 2022Quarterly reportSEC
4 · Change in ownershipAug 5, 2022Insider tradeSEC
4 · Change in ownershipAug 5, 2022Insider tradeSEC
4 · Change in ownershipAug 5, 2022Insider tradeSEC
4 · Change in ownershipAug 5, 2022Insider tradeSEC
8-K · Current reportAug 1, 2022Current reportSEC
4 · Change in ownershipJul 6, 2022Insider tradeSEC
8-K · Current reportJun 10, 2022Current reportSEC
10-Q · Quarterly reportMay 23, 2022Quarterly reportSEC
NT 10-Q · Late filing noticeMay 16, 2022Explanation requestSEC
4 · Change in ownershipMay 13, 2022Insider tradeSEC
4 · Change in ownershipMay 13, 2022Insider tradeSEC
4 · Change in ownershipMay 13, 2022Insider tradeSEC
S-1 · Registration statementApr 12, 2022Offer documentSEC
10-K · Annual reportApr 11, 2022Annual reportSEC
4 · Change in ownershipApr 7, 2022Insider tradeSEC
NT 10-K · Late filing noticeMar 29, 2022Explanation requestSEC
RW · Request to withdraw a registrationFeb 28, 2022Other filingsSEC
5 · Annual statement of ownershipJan 28, 2022Insider tradeSEC
5 · Annual statement of ownershipJan 28, 2022Insider tradeSEC
5 · Annual statement of ownershipJan 28, 2022Insider tradeSEC
5 · Annual statement of ownershipJan 28, 2022Insider tradeSEC
5 · Annual statement of ownershipJan 28, 2022Insider tradeSEC
5 · Annual statement of ownershipJan 28, 2022Insider tradeSEC
5 · Annual statement of ownershipJan 28, 2022Insider tradeSEC
5 · Annual statement of ownershipJan 28, 2022Insider tradeSEC
4 · Change in ownershipJan 28, 2022Insider tradeSEC
3 · Initial statement of ownershipJan 27, 2022Insider tradeSEC
4 · Change in ownershipJan 18, 2022Insider tradeSEC
4 · Change in ownershipJan 18, 2022Insider tradeSEC
4 · Change in ownershipJan 18, 2022Insider tradeSEC
4 · Change in ownershipJan 18, 2022Insider tradeSEC
4 · Change in ownershipJan 18, 2022Insider tradeSEC
4 · Change in ownershipJan 18, 2022Insider tradeSEC
8-K · Current reportJan 14, 2022Material contractSEC
DJan 13, 2022Other filingsSEC
10-Q · Quarterly reportNov 17, 2021Quarterly reportSEC
NT 10-Q · Late filing noticeNov 12, 2021Explanation requestSEC
10-Q · Quarterly reportAug 10, 2021Quarterly reportSEC
424B4 · ProspectusJul 26, 2021Offer documentSEC
424B4 · ProspectusJul 26, 2021Offer documentSEC
EFFECT · Notice that a registration is effectiveJul 26, 2021Other filingsSEC
CORRESP · Letter to the SECJul 22, 2021Other filingsSEC
DJul 20, 2021Other filingsSEC
S-1/A · Registration statement, amendedJul 19, 2021Offer documentSEC
8-K · Current reportJul 16, 2021Management or board changeSEC
UPLOAD · Letter from the SECJul 1, 2021Other filingsSEC
S-1 · Registration statementJun 24, 2021Offer documentSEC

This page holds 200 of 473 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Bioxytran, Inc.’s releases · as of Nov 19, 2026

Common shares
114,695,220
Fully diluted
114,695,220

Fully diluted

LineSharesAs of
Common shares114,695,220Nov 19, 2026

Share count over time

CountShares
Nov 19, 2026114,695,220

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Dale H. Conaway
Other companies: Boston Therapeutics Inc (Director · Apr 4, 2014 – May 15, 2015 · Past); Galectin Therapeutics Inc. (Director · Mar 9, 2006 – Feb 8, 2009 · Past)
Director · Since at least Jul 1, 2020
Alan M. HobermanDirector · Since at least Aug 12, 2025
Anders UtterDirector · Since at least Jul 1, 2020
Dave Quincy FarberPresident, Director · Dec 8, 2017 – Dec 8, 2017 · Past
David PlattCEO & Chairman of the Board · Since at least Oct 24, 2024
Dennis CullisonPresident/Treasurer, Director · Apr 13, 2009 – Aug 7, 2012 · Past
Donita R KendigSecretary/Treasurer, Director · Dec 8, 2017 – Dec 8, 2017 · Past
Hana Chen-WaldenDirector · Jul 15, 2021 – Dec 31, 2023 · Past
John BirchardPresident, Director · Jun 8, 2008 – Jun 8, 2008 · Past
Leslie AjayiCMO & Medical Advisory Board Chief · Since at least Nov 4, 2026
All 15 people
PersonSeat
Michael SheikhChief Communications Officer · Aug 19, 2024 – Oct 25, 2024 · Past
Nathan MarksDirector · Dec 8, 2017 – Dec 8, 2017 · Past
Ola SoderquistCFO · Since at least Aug 19, 2024
Paul W HaitSecretary, Director · Apr 13, 2009 – Aug 7, 2012 · Past
Radka MilanovaDirector · Since at least Jan 19, 2024

Open People

Log in to ask 6ix AI your own questions about Bioxytran, Inc.